Company Performance: Revenue, profit margins, and overall financial health significantly impact investor confidence and stock price.

Industry Trends: The performance of the broader healthcare and pharmaceutical industry influences investor sentiment towards Jiangsu Hengrui Medicine, impacting its stock valuation.

Regulatory Environment: Changes in drug approval processes, pricing policies, and healthcare regulations in China affect Hengrui's potential for growth and profitability.

Drug Pipeline: The success and progress of Hengrui's drug development pipeline, including clinical trial results and new drug approvals, drive investor expectations and stock price.

Market Sentiment: General market conditions, investor risk appetite, and overall economic outlook influence the demand for stocks, including 600348.SHG.

Competition: The competitive landscape in the pharmaceutical industry, including the emergence of new drugs and competitors, affects Hengrui's market share and pricing power.

Global Events: Global economic events, geopolitical tensions, and international trade policies can impact the Chinese stock market and individual stocks like 600348.SHG.

Investor Relations: Company communications, transparency, and investor outreach efforts influence investor perception and stock valuation.

Analyst Ratings: Ratings and price targets from financial analysts can influence investor decisions and affect stock price movements.

Shareholder Structure: The ownership structure of the company and the actions of major shareholders can impact stock price volatility.

Technological Advancements: New technological breakthroughs in drug discovery and manufacturing can affect Hengrui's competitive advantage and stock valuation.